JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors is a paper indexed in ScholarIQ from OpenAlex.
How many citations does JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors have?
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors has 157 citations in the OpenAlex counts ScholarIQ stores.
When was JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors published?
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors has 2020 year in the ScholarIQ index.
What is the open-access status of JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors?
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors has closed oa status in the ScholarIQ index.
What is the DOI of JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors?
The DOI for JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors is on the source record.
What is the PMID of JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors?
The PMID for JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors is on the source record.
What is the OpenAlex record for JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors?
The OpenAlex for JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors is on the source record.